Healthcare - Biotechnology - NASDAQ - CA
$ 0.3649
-4.23 %
$ 7.12 M
Market Cap
-0.09
P/E
INCOME STATEMENT
0
REVENUE
-52.4 M
OPERATING INCOME
-51.2 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Aptose Biosciences Inc.
| Revenue | 0 |
| Cost Of Revenue | 475 K |
| Gross Profit | -475 K |
| Operating Expenses | 52.4 M |
| Operating Income | -52.4 M |
| Other Expenses | -1.15 M |
| Net Income | -51.2 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | May-2014 | May-2013 | May-2012 | May-2011 | May-2010 | May-2009 | May-2008 | May-2007 | May-2006 | May-2005 | May-2004 | May-2003 | May-2002 | May-2001 | May-2000 | May-1999 | May-1998 | May-1997 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.2 | 43 K | 0.1 | 24 K | 5 K | 0.4 | 47.8 K | 0 | 1 K | 667 | 67.8 K | 68.7 K | 72.6 K |
| GROSS PROFIT | ||||||||||||||||||||||||||||
| Cost Of Revenue | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 83.5 K | 89.1 K | 0.1 | 69.1 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 K | 15 K | 3 K | 1 K | 21 K | 39.9 K | 0 | (1.2) | (0.9) | (0.2) | 68.7 K | 0 |
| Gross Profit | (0.5) | (0.5) | (0.6) | (0.6) | (0.6) | 83.5 K | 89.1 K | (0.1) | 69.1 K | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.2 | 41 K | 85 K | 21 K | 4 K | 0.4 | 7.97 K | 0 | 1.2 | 0.9 | 0.3 | 0.1 | 72.6 K |
| OPERATING INCOME | ||||||||||||||||||||||||||||
| Operating Expenses | 52.4 | 42.6 | 65.4 | 55.8 | 26.9 | 29.1 | 11.8 | 13.9 | 11.6 | 11.8 K | 8.9 | 5.4 | 4.5 | 5.1 | 5.4 | 6.7 | 11.1 | 7.7 | 15.1 | (17.4) | 23.6 | (13.0) | 10.1 | 13.0 | 7.0 | 3.5 | 3.5 | 3.6 |
| Selling, General and Administrative Expenses | 15.6 | 14.4 | 19.3 | 26.3 | 9.9 | 10.3 | 5.5 | 6.1 | 7.0 | 8.2 K | 6.1 | 2.2 | 2.5 | 2.7 | 3.0 | 3.1 | 4.6 | 4.1 | 5.0 | 5.4 | 3.6 | 3.1 | 3.2 | 4.2 | 2.4 | 1.2 | 1.3 | 1.1 |
| Research and Development Expenses | 36.8 | 28.1 | 46.0 | 29.3 | 16.8 | 18.7 | 6.3 | 7.7 | 4.5 | 3.56 K | 2.8 | 3.2 | 1.9 | 2.4 | 2.4 | 3.4 | 6.1 | 3.2 | 9.3 | 11.5 | 19.7 | 9.1 | 5.7 | 6.4 | 2.8 | 2.2 | 1.9 | 2.1 |
| Operating Income | (52.4) | (42.6) | (65.4) | (55.8) | (26.9) | (29.1) | (11.8) | (13.9) | (11.6) | 11.8 K | (8.9) | (5.4) | (4.5) | (5.1) | (5.3) | (6.6) | (11.0) | (7.6) | (15.1) | 17.4 | (23.2) | 13.0 | (10.1) | (11.8) | (6.1) | (3.3) | (3.4) | (3.6) |
| PRE-TAX INCOME | ||||||||||||||||||||||||||||
| Interest Income Expense | 0 | (0.8) | 0 | 0 | 0 | 0 | 0 | 49.1 K | 31 K | 0 | 0.2 | 5.82 K | 19.4 K | 14.3 K | 51.2 K | 0.6 | 1.0 | 1.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 1.1 | 0.8 | 93 K | 0.5 | 0.6 | 0.2 | 0.2 | 60.6 K | 1.1 | 259 | (0.9) | 23.3 K | 36.5 K | 58.8 K | 10.4 | 0 | 0 | (1.4) | (1.5) | 17.4 | 0.9 | (25.1) | 1.3 | 1.9 | 0.4 | 0.2 | 0.1 | 0 |
| Pre-Tax Income | (51.2) | (41.8) | (65.4) | (55.2) | (26.3) | (28.9) | (11.7) | (13.9) | (10.5) | 11.5 K | (9.7) | (5.4) | (4.5) | (5.2) | 5.1 | (8.1) | (6.4) | (9.0) | (16.3) | (17.6) | (22.2) | (12.1) | (8.8) | (9.9) | (5.7) | (3.1) | (3.2) | (3.5) |
| NET INCOME | ||||||||||||||||||||||||||||
| Tax Provision | 0 | (0.8) | 93 K | (0.5) | (0.6) | 44 K | 97 K | 35.2 K | 31 K | 0 | 0.2 | (5.4) | 4.5 | 5.2 | (5.1) | 8.1 | 6.4 | 9.0 | 16.3 | 17.6 | 22.2 | 12.1 | 8.8 | 9.9 | 5.7 | 3.1 | 3.2 | 3.5 |
| Net Income | (51.2) | (41.1) | (65.3) | (54.7) | (25.7) | (28.9) | (11.7) | (13.9) | (10.5) | 11.5 K | (9.7) | (5.4) | (4.5) | (5.2) | 5.1 | (8.1) | (6.4) | (9.0) | (16.3) | (17.6) | (22.2) | (12.1) | (8.8) | (9.9) | (5.7) | (3.1) | (3.2) | (3.5) |
| EPS | 7.58 | 6.67 | 11 | 10 | 7.68 | 13 | 7.84 | 16.3 | 13.3 | 0.0149 | 12.6 | 23 | 38.3 | 92.1 | 97.2 | 178 | 160 | 238 | 506 | 552 | 700 | 453 | 332 | 380 | 720 | 445 | 482 | 627 |